Role of phenol-soluble modulins in formation of Staphylococcus aureus biofilms in synovial fluid

Infection and Immunity

Volumn 83, Issue 7, 2015, Pages 2966-2975

  Dastgheyb, Sana S ^a,b   Villaruz, Amer E ^a   Le, Katherine Y ^a   Tan, Vee Y ^a   Duong, Anthony C ^a   Chatterjee, Som S ^a,c   Cheung, Gordon Y C ^a   Joo, Hwang Soo ^a   Hickok, Noreen J ^b   Otto, Michael ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSORY GENE REGULATOR PROTEIN; ADHESIN; FIBRIN; MEMBRANE PROTEIN; PEPTIDE; PHENOL SOLUBLE MODULIN; POLYSACCHARIDE INTERCELLULAR ADHESIN; UNCLASSIFIED DRUG; BACTERIAL TOXIN; STAPHYLOCOCCAL DELTA TOXIN; SURFACTANT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; BIOFILM; CELL SURFACE; CONTROLLED STUDY; HUMAN; INFECTIOUS ARTHRITIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYNOVIAL FLUID; GROWTH, DEVELOPMENT AND AGING; INFECTION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

BACTERIAL TOXINS; BIOFILMS; HUMANS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURFACE-ACTIVE AGENTS; SYNOVIAL FLUID;

EID: 84930986579     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00394-15     Document Type: Article

References (44)

1. Shirtliff ME, Mader JT. 2002. Acute septic arthritis. Clin Microbiol Rev 15:527-544. http://dx.doi.org/10.1128/CMR.15.4.527-544.2002.
2. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. 2012. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 27:61-65.e1. http://dx.doi.org/10.1016/j.arth.2012.02.022.
3. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N Engl J Med 351:1645-1654. http://dx.doi.org/10.1056/NEJMra040181.
4. Dastgheyb S, Parvizi J, Shapiro IM, Hickok NJ, Otto M. 2015. Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis 211:641-650. http://dx.doi.org/10.1093/infdis /jiu514.
5. Donlan RM. 2001. Biofilms and device-associated infections. Emerg Infect Dis 7:277-281. http://dx.doi.org/10.3201/eid0702.010226.
6. Otto M. 2008. Staphylococcal biofilms. Curr Top Microbiol Immunol 322:207-228.
7. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. 1999. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 67:5427-5433.
8. Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, Laufs R. 1996. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 178:175-183.
9. Lack CH. 1959. Chondrolysis in arthritis. J Bone Joint Surg Br 41-B:384-387.
10. Kornblum J, Kreiswirth B, Projan SJ, Ross H, Novick RP. 1990. agr; a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus, p 373-402. In Novick RP (ed), Molecular biology of the staphylococci. VCH Publishers, New York, NY.
11. Vuong C, Saenz HL, Gotz F, Otto M. 2000. Impact of the agr quorumsensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 182:1688-1693. http://dx.doi.org/10.1086/317606.
12. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. 2004. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 186:1838-1850. http: //dx.doi.org/10.1128/JB.186.6.1838-1850.2004.
13. Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, Chatterjee SS, Cheung GY, Otto M. 2012. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A 109:1281-1286. http://dx.doi.org/10.1073/pnas.1115006109.
14. Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. 2004. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 190:1498-1505. http://dx .doi.org/10.1086/424487.
15. Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, Queck SY, Otto M. 2011. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121:238-248. http://dx.doi.org/10.1172 /JCI42520.
16. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32:150-158. http://dx.doi.org/10.1016/j.molcel.2008.08.005.
17. Peschel A, Otto M. 2013. Phenol-soluble modulins and staphylococcal infection. Nat Rev Microbiol 11:667-673. http://dx.doi.org/10.1038 /nrmicro3110.
18. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510-1514. http: //dx.doi.org/10.1038/nm1656.
19. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. 2005. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 33:385-391. http://dx.doi.org/10.1016/j.ajic.2005.06.006.
20. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568. http://dx.doi.org/10.1016/S0140-6736(09)61999-1.
21. Joo HS, Cheung GY, Otto M. 2011. Antimicrobial activity of community- associated methicillin-resistant Staphylococcus aureus is caused by phenol- soluble modulin derivatives. J Biol Chem 286:8933-8940. http://dx .doi.org/10.1074/jbc.M111.221382.
22. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hasegawa M, Villaruz AE, Cheung GY, McGavin MJ, Travers JB, Otto M, Inohara N, Nunez G. 2013. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 503:397-401. http://dx.doi .org/10.1038/nature12655.
23. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66:1136-1147. http://dx.doi.org/10.1111/j.1365-2958 .2007.05986.x.
24. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68:3594-3600. http://dx.doi.org/10.1128/IAI.68.6.3594-3600.2000.
25. Luong TT, Lee CY. 2007. Improved single-copy integration vectors for Staphylococcus aureus. J Microbiol Methods 70:186-190. http://dx.doi.org /10.1016/j.mimet.2007.04.007.
26. Cramton SE, Gerke C, Gotz F. 2001. In vitro methods to study staphylococcal biofilm formation. Methods Enzymol 336:239-255. http://dx.doi .org/10.1016/S0076-6879(01)36593-X.
27. Joo HS, Otto M. 2014. The isolation and analysis of phenol-soluble modulins of Staphylococcus epidermidis. Methods Mol Biol 1106:93-100. http://dx.doi.org/10.1007/978-1-62703-736-5_7.
28. Dastgheyb S, Hammoud S, Ketonis C, Liu AY, Fitzgerald K, Parvizi J, Purtill J, Ciccotti M, Shapiro IM, Otto M, Hickok NJ. 2015. Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin. Antimicrob Agents Chemother 59:2122-2128. http://dx.doi.org/10.1128/AAC.04579-14.
29. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12:3967-3975.
30. Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet 248:446-458. http://dx.doi.org/10.1007/BF02191645.
31. Hall PR, Elmore BO, Spang CH, Alexander SM, Manifold-Wheeler BC, Castleman MJ, Daly SM, Peterson MM, Sully EK, Femling JK, Otto M, Horswill AR, Timmins GS, Gresham HD. 2013. Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing. PLoS Pathog 9:e1003166. http: //dx.doi.org/10.1371/journal.ppat.1003166.
32. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. 2003. Quorumsensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706-718. http://dx.doi.org/10.1086/377239.
33. Redfield RJ. 2002. Is quorum sensing a side effect of diffusion sensing? Trends Microbiol 10:365-370. http://dx.doi.org/10.1016/S0966-842X(02)02400-9.
34. Blau S, Janis R, Hamerman D, Sandson J. 1965. Cellular origin of hyaluronateprotein in human synovial membrane. Science 150:353-355. http://dx.doi.org/10.1126/science.150.3694.353.
35. Ropes MW, Rossmeisl EC, Bauer W. 1940. The origin and nature of normal human synovial fluid. J Clin Invest 19:795-799. http://dx.doi.org /10.1172/JCI101182.
36. Kim WJ, Ahn YS, Kim SJ, Jahng JS, Hong SS. 1976. Study on the fractionation of synovial fluid protein. Yonsei Med J 17:109-114. http: //dx.doi.org/10.3349/ymj.1976.17.2.109.
37. Peterson MM, Mack JL, Hall PR, Alsup AA, Alexander SM, Sully EK, Sawires YS, Cheung AL, Otto M, Gresham HD. 2008. Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe 4:555-566. http://dx.doi.org/10.1016/j.chom.2008.10 .001.
38. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. 2012. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog 8:e1002744. http://dx.doi .org/10.1371/journal.ppat.1002744.
39. Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B, Novick RP. 2008. agr function in clinical Staphylococcus aureus isolates. Microbiology 154:2265-2274. http://dx.doi.org/10.1099/mic.0.2007/011874-0.
40. Fowler VG, Jr, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS. 2004. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis 190:1140-1149. http://dx.doi.org/10 .1086/423145.
41. Bubeck Wardenburg J, Bae T, Otto M, DeLeo FR, Schneewind O. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-1406. http://dx.doi .org/10.1038/nm1207-1405.
42. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. 2011. Role of the accessory gene regulator agr in community-associated methicillinresistant Staphylococcus aureus pathogenesis. Infect Immun 79:1927-1935. http://dx.doi.org/10.1128/IAI.00046-11.
43. Cassat JE, Hammer ND, Campbell JP, Benson MA, Perrien DS, Mrak LN, Smeltzer MS, Torres VJ, Skaar EP. 2013. A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe 13:759-772. http://dx.doi.org/10.1016/j.chom.2013.05.003.
44. Khan BA, Yeh AJ, Cheung GY, Otto M. 2015. Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections. Expert Opin Invest Drugs 24:689-704. http://dx.doi.org/10.1517 /13543784.2015.1019062.